Participants’ understanding of informed consent in clinical trials over three decades: Systematic review and meta-analysis;Compréhension du consentement éclairé par les participants à des essais cliniques sur trois décennies: Revue systématique et méta-analyse;La comprensión del consentimiento informado por parte de los participantes de ensayos clínicos a lo largo de tres décadas: Revisión sistemática y metaanálisis

Bulletin of the World Health Organization

Volumn 93, Issue 3, 2015, Pages 186-198

  Tam, Ng Uyen Thanh ^a   Thoa, Le Thi Bich ^a   Long, Nguyen Phuoc ^a   Trang, Nguyen Thi Huyen ^c   Hirayama, Kenji ^b   Karbwang, Juntra ^b   Huy, Nguyen Tien ^b  

^a UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY   (Viet Nam)

^b NAGASAKI UNIVERSITY   (Japan)

^c HUE UNIVERSITY   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH RISK; HETEROGENEITY; LITERATURE REVIEW; META-ANALYSIS; NUMERICAL MODEL; PARTICIPATORY APPROACH;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL RESEARCH; CONFIDENCE INTERVAL; CONFIDENTIALITY; DATA EXTRACTION; DATA SYNTHESIS; DECISION MAKING; HUMAN; INFECTION; INFORMED CONSENT; INTERVIEW; NEOPLASM; NEUROLOGY; PATIENT PARTICIPATION; QUESTIONNAIRE; REGRESSION ANALYSIS; SYSTEMATIC REVIEW; THERAPEUTIC MISCONCEPTION; ADULT; CLINICAL TRIAL (TOPIC); COMPREHENSION; FEMALE; HEALTH LITERACY; MALE; META ANALYSIS; MIDDLE AGED; PSYCHOLOGY; RESEARCH SUBJECT; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

SCOPUS;

ADULT; CLINICAL TRIALS AS TOPIC; COMPREHENSION; FEMALE; HEALTH LITERACY; HUMANS; INFORMED CONSENT; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RESEARCH SUBJECTS; YOUNG ADULT;

EID: 84923863238     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.14.141390     Document Type: Article

References (154)

1. Grodin MA, Annas GJ. Legacies of Nuremberg. Medical ethics and human rights. JAMA. 1996 Nov 27;276 (20):1682-3.doi: http://dx.doi.org/10.1001/jama.1996.03540200068035PMID: 8922458.
2. Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA. 2000 May 24-31;283 (20):2701-11.doi: http://dx.doi.org/10.1001/jama.283.20.2701PMID: 10819955.
3. Annas GJ. Doctors, patients, and lawyers-two centuries of health law. N Engl J Med. 2012 Aug 2;367 (5):445-50.doi: http://dx.doi.org/10.1056/NEJMra1108646PMID: 22853015.
4. Jefford M, Moore R. Improvement of informed consent and the quality of consent documents. Lancet Oncol. 2008 May;9 (5):485-93.doi: http://dx.doi.org/10.1016/S1470-2045 (08)70128-1PMID: 18452859.
5. Will JF. A brief historical and theoretical perspective on patient autonomy and medical decision making: Part II: The autonomy model. Chest. 2011 Jun;139 (6):1491-7.doi: http://dx.doi.org/10.1378/chest.11-0516PMID: 21652559.
6. Wendler D. How to enroll participants in research ethically. JAMA. 2011 Apr 20;305 (15):1587-8.doi: http://dx.doi.org/10.1001/jama.2011.421PMID: 21505137.
7. Glickman SW, McHutchison JG, Peterson ED, Cairns CB, Harrington RA, Califf RM, et al. Ethical and scientific implications of the globalization of clinical research. N Engl J Med. 2009 Feb 19;360 (8):816-23.doi: http://dx.doi.org/10.1056/NEJMsb0803929PMID: 19228627.
8. Rivera R, Borasky D, Rice R, Carayon F, Wong E. Informed consent: an international researchers’ perspective. Am J Public Health. 2007 Jan;97 (1):25-30.doi: http://dx.doi.org/10.2105/AJPH.2005.081604PMID: 17138913.
9. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013 Nov 27;310 (20):2191-4.doi: http://dx.doi.org/10.1001/jama.2013.281053PMID: 24141714.
10. Boga M, Davies A, Kamuya D, Kinyanjui SM, Kivaya E, Kombe F, et al. Strengthening the informed consent process in international health research through community engagement: The KEMRI-Wellcome Trust Research Programme Experience. PLoS Med. 2011 Sep;8 (9):e1001089.doi: http://dx.doi.org/10.1371/journal.pmed.1001089PMID: 21931539.
11. del Carmen MG, Joffe S. Informed consent for medical treatment and research: a review. Oncologist. 2005 Sep;10 (8):636-41.doi: http://dx.doi.org/10.1634/theoncologist.10-8-636PMID: 16177288.
12. Beauchamp TL, Childress JF. Principles of biomedical ethics. New York: Oxford University Press; 2001.
13. Weijer C, Grimshaw JM, Eccles MP, McRae AD, White A, Brehaut JC, et al.; Ottawa Ethics of Cluster Randomized Trials Consensus Group. The Ottawa Statement on the Ethical Design and Conduct of Cluster Randomized Trials. PLoS Med. 2012;9 (11):e1001346.doi: http://dx.doi.org/10.1371/journal.pmed.1001346PMID: 23185138.
14. Sreenivasan G. Does informed consent to research require comprehension? Lancet. 2003 Dec 13;362 (9400):2016-8.doi: http://dx.doi.org/10.1016/S0140-6736 (03)15025-8PMID: 14683665.
15. Lad PM, Dahl R. Audit of the informed consent process as a part of a clinical research quality assurance program. Sci Eng Ethics. 2014 Jun;20 (2):469-79.doi: http://dx.doi.org/10.1007/s11948-013-9461-4PMID: 23975172.
16. Richardson V. Patient comprehension of informed consent. J Perioper Pract. 2013 Jan-Feb;23 (1-2):26-30.PMID: 23413533.
17. Bhutta ZA. Beyond informed consent. Bull World Health Organ. 2004 Oct;82 (10):771-7.PMID: 15643799.
18. Falagas ME, Korbila IP, Giannopoulou KP, Kondilis BK, Peppas G. Informed consent: how much and what do patients understand? Am J Surg. 2009 Sep;198 (3):420-35.doi: http://dx.doi.org/10.1016/j.amjsurg.2009.02.010PMID: 19716887.
19. Mandava A, Pace C, Campbell B, Emanuel E, Grady C. The quality of informed consent: mapping the landscape. A review of empirical data from developing and developed countries. J Med Ethics. 2012 Jun;38 (6):356-65.doi: http://dx.doi.org/10.1136/medethics-2011-100178PMID: 22313664.
20. Aromataris E, Riitano D. Constructing a search strategy and searching for evidence. A guide to the literature search for a systematic review. Am J Nurs. 2014 May;114 (5):49-56.doi: http://dx.doi.org/10.1097/01.NAJ.0000446779.99522.f6PMID: 24759479.
21. Protection of human subjects. Code Fed Requl Public Welfare. Washington: U.S. Department of Health and Human Services; 1995 Oct 1;Title 4s: sections 46-101 to 46-409.
22. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000 Apr 19;283 (15):2008-12.doi: http://dx.doi.org/10.1001/jama.283.15.2008PMID: 10789670.
23. Sedgwick P. Meta-analyses: heterogeneity and subgroup analysis. BMJ. 2013 June 24;346 jun24 2:f4040.doi: http://dx.doi.org/10.1136/bmj.f4040.
24. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006 Feb 8;295 (6):676-80.doi: http://dx.doi.org/10.1001/jama.295.6.676PMID: 16467236.
25. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000 Jun;56 (2):455-63.doi: http://dx.doi.org/10.1111/j.0006-341X.2000.00455.xPMID: 10877304.
26. Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis. 2009 Feb;9 (2):89-96.doi: http://dx.doi.org/10.1016/S1473-3099 (09)70019-2PMID: 19179225.
27. Kaufert JM, O’Neil J. Culture, power and informed consent: the impact of Aboriginal health interpreters on decision-making. In: Coburn D, D’Arcy C, Torrance G, editors. Health and Canadian society: sociological perspectives. Toronto: University of Toronto Press; 1998.
28. Ellis RD, Sagara I, Durbin A, Dicko A, Shaffer D, Miller L, et al. Comparing the understanding of subjects receiving a candidate malaria vaccine in the United States and Mali. Am J Trop Med Hyg. 2010 Oct;83 (4):868-72.doi: http://dx.doi.org/10.4269/ajtmh.2010.10-0062PMID: 20889881.
29. Vallely A, Lees S, Shagi C, Kasindi S, Soteli S, Kavit N, et al.; Microbicides Development Programme (MDP). How informed is consent in vulnerable populations? Experience using a continuous consent process during the MDP301 vaginal microbicide trial in Mwanza, Tanzania. BMC Med Ethics. 2010;11 (1):10.doi: http://dx.doi.org/10.1186/1472-6939-11-10PMID: 20540803.
30. Hill Z, Tawiah-Agyemang C, Odei-Danso S, Kirkwood B. Informed consent in Ghana: what do participants really understand? J Med Ethics. 2008 Jan;34 (1):48-53.doi: http://dx.doi.org/10.1136/jme.2006.019059PMID: 18156522.
31. Minnies D, Hawkridge T, Hanekom W, Ehrlich R, London L, Hussey G. Evaluation of the quality of informed consent in a vaccine field trial in a developing country setting. BMC Med Ethics. 2008;9 (1):15.doi: http://dx.doi.org/10.1186/1472-6939-9-15PMID: 18826637.
32. Kaewpoonsri N, Okanurak K, Kitayaporn D, Kaewkungwal J, Vijaykadga S, Thamaree S. Factors related to volunteer comprehension of informed consent for a clinical trial. Southeast Asian J Trop Med Public Health. 2006 Sep;37 (5):996-1004.PMID: 17333746.
33. Krosin MT, Klitzman R, Levin B, Cheng J, Ranney ML. Problems in comprehension of informed consent in rural and peri-urban Mali, West Africa. Clin Trials. 2006;3 (3):306-13.doi: http://dx.doi.org/10.1191/1740774506cn150oaPMID: 16895047.
34. Moodley K, Pather M, Myer L. Informed consent and participant perceptions of influenza vaccine trials in South Africa. J Med Ethics. 2005 Dec;31 (12):727-32.doi: http://dx.doi.org/10.1136/jme.2004.009910PMID: 16319239.
35. Pace C, Emanuel EJ, Chuenyam T, Duncombe C, Bebchuk JD, Wendler D, et al. The quality of informed consent in a clinical research study in Thailand. IRB. 2005 Jan-Feb;27 (1):9-17.doi: http://dx.doi.org/10.2307/3563866PMID: 15835065.
36. Pace C, Talisuna A, Wendler D, Maiso F, Wabwire-Mangen F, Bakyaita N, et al. Quality of parental consent in a Ugandan malaria study. Am J Public Health. 2005 Jul;95 (7):1184-9.doi: http://dx.doi.org/10.2105/AJPH.2004.053082PMID: 15933235.
37. ANRS1201/1202 Ditrame Plus Study Group. Obtaining informed consent from HIV-infected pregnant women, Abidjan, Côte d’Ivoire. AIDS. 2004 Jul 2;18 (10):1486-8.doi: http://dx.doi.org/10.1097/01.aids.0000131349.22032.63PMID: 15199334.
38. Joubert G, Steinberg H, van der Ryst E, Chikobvu P. Consent for participation in the Bloemfontein vitamin A trial: how informed and voluntary? Am J Public Health. 2003 Apr;93 (4):582-4.doi: http://dx.doi.org/10.2105/AJPH.93.4.582PMID: 12660201.
39. Lynöe N, Hyder Z, Chowdhury M, Ekström L. Obtaining informed consent in Bangladesh. N Engl J Med. 2001 Feb 8;344 (6):460-1.doi: http://dx.doi.org/10.1056/NEJM200102083440617PMID: 11221611.
40. Lynöe N, Näsström B, Sandlund M. Study of the quality of information given to patients participating in a clinical trial regarding chronic hemodialysis. Scand J Urol Nephrol. 2004;38 (6):517-20.doi: http://dx.doi.org/10.1080/00365590410033362PMID: 15841789.
41. Lynöe N, Sandlund M, Dahlqvist G, Jacobsson L. Informed consent: study of quality of information given to participants in a clinical trial. BMJ. 1991 Sep 14;303 (6803):610-3.doi: http://dx.doi.org/10.1136/bmj.303.6803.610PMID: 1932901.
42. Lynöe N, Boman K, Andersson H, Sandlund M. Informed consent and participants’ inclination to delegate decision-making to the doctor. Acta Oncol. 2004;43 (8):769.doi: http://dx.doi.org/10.1080/02841860410002734PMID: 15764224.
43. Lynöe N, Sandlund M, Jacobsson L. Informed consent in two Swedish prisons: a study of quality of information and reasons for participating in a clinical trial. Med Law. 2001;20 (4):515-23.PMID: 11817382.
44. Leach A, Hilton S, Greenwood BM, Manneh E, Dibba B, Wilkins A, et al. An evaluation of the informed consent procedure used during a trial of a Haemophilus influenzae type B conjugate vaccine undertaken in the Gambia, West Africa. Soc Sci Med. 1999 Jan;48 (2):139-48.doi: http://dx.doi.org/10.1016/S0277-9536 (98)00317-7PMID: 10048773.
45. Pitisuttithum P, Migasena S, Laothai A, Suntharasamai P, Kumpong C, Vanichseni S. Risk behaviours and comprehension among intravenous drug users volunteered for HIV vaccine trial. J Med Assoc Thai. 1997 Jan;80 (1):47-50.PMID: 9078816.
46. Bergenmar M, Molin C, Wilking N, Brandberg Y. Knowledge and understanding among cancer patients consenting to participate in clinical trials. Eur J Cancer. 2008 Nov;44 (17):2627-33.doi: http://dx.doi.org/10.1016/j.ejca.2008.08.013PMID: 18818068.
47. Knifed E, Lipsman N, Mason W, Bernstein M. Patients’ perception of the informed consent process for neurooncology clinical trials. Neuro-oncol. 2008 Jun;10 (3):348-54.doi: http://dx.doi.org/10.1215/15228517-2008-007PMID: 18388256.
48. Agrawal M, Grady C, Fairclough DL, Meropol NJ, Maynard K, Emanuel EJ. Patients’ decision-making process regarding participation in phase I oncology research. J Clin Oncol. 2006 Sep 20;24 (27):4479-84.doi: http://dx.doi.org/10.1200/JCO.2006.06.0269PMID: 16983117.
49. Franck LS, Winter I, Oulton K. The quality of parental consent for research with children: a prospective repeated measure self-report survey. Int J Nurs Stud. 2007 May;44 (4):525-33.doi: http://dx.doi.org/10.1016/j.ijnurstu.2006.03.014PMID: 16712850.
50. Gammelgaard A, Mortensen OS, Rossel P; DANAMI-2 Investigators. Patients’ perceptions of informed consent in acute myocardial infarction research: a questionnaire based survey of the consent process in the DANAMI-2 trial. Heart. 2004 Oct;90 (10):1124-8.doi: http://dx.doi.org/10.1136/hrt.2003.021931PMID: 15367504.
51. Kodish E, Eder M, Noll RB, Ruccione K, Lange B, Angiolillo A, et al. Communication of randomization in childhood leukemia trials. JAMA. 2004 Jan 28;291 (4):470-5.doi: http://dx.doi.org/10.1001/jama.291.4.470PMID: 14747504.
52. Criscione LG, Sugarman J, Sanders L, Pisetsky DS, St Clair EW. Informed consent in a clinical trial of a novel treatment for rheumatoid arthritis. Arthritis Rheum. 2003 Jun 15;49 (3):361-7.doi: http://dx.doi.org/10.1002/art.11057PMID: 12794792.
53. Kupst MJ, Patenaude AF, Walco GA, Sterling C. Clinical trials in pediatric cancer: parental perspectives on informed consent. J Pediatr Hematol Oncol. 2003 Oct;25 (10):787-90.doi: http://dx.doi.org/10.1097/00043426-200310000-00009PMID: 14528101.
54. Pope JE, Tingey DP, Arnold JM, Hong P, Ouimet JM, Krizova A. Are subjects satisfied with the informed consent process? A survey of research participants. J Rheumatol. 2003 Apr;30 (4):815-24.PMID: 12672205.
55. Schats R, Brilstra EH, Rinkel GJ, Algra A, Van Gijn J. Informed consent in trials for neurological emergencies: the example of subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2003 Jul;74 (7):988-91.doi: http://dx.doi.org/10.1136/jnnp.74.7.988PMID: 12810803.
56. Simon C, Zyzanski SJ, Eder M, Raiz P, Kodish ED, Siminoff LA. Groups potentially at risk for making poorly informed decisions about entry into clinical trials for childhood cancer. J Clin Oncol. 2003 Jun 1;21 (11):2173-8.doi: http://dx.doi.org/10.1200/JCO.2003.03.003PMID: 12775743.
57. Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC. Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet. 2001 Nov 24;358 (9295):1772-7.doi: http://dx.doi.org/10.1016/S0140-6736 (01)06805-2PMID: 11734235.
58. Daugherty C, Ratain MJ, Grochowski E, Stocking C, Kodish E, Mick R, et al. Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol. 1995 May;13 (5):1062-72.PMID: 7738612.
59. Daugherty CK, Banik DM, Janish L, Ratain MJ. Quantitative analysis of ethical issues in phase I trials: a survey interview of 144 advanced cancer patients. IRB. 2000 May-Jun;22 (3):6-14.doi: http://dx.doi.org/10.2307/3564113PMID: 11697385.
60. Hietanen P, Aro AR, Holli K, Absetz P. Information and communication in the context of a clinical trial. Eur J Cancer. 2000 Oct;36 (16):2096-104.doi: http://dx.doi.org/10.1016/S0959-8049 (00)00191-XPMID: 11044647.
61. Montgomery JE, Sneyd JR. Consent to clinical trials in anaesthesia. Anaesthesia. 1998 Mar;53 (3):227-30.doi: http://dx.doi.org/10.1046/j.1365-2044.1998.00309.xPMID: 9613266.
62. van Stuijvenberg M, Suur MH, de Vos S, Tjiang GC, Steyerberg EW, Derksen-Lubsen G, et al. Informed consent, parental awareness, and reasons for participating in a randomised controlled study. Arch Dis Child. 1998 Aug;79 (2):120-5.doi: http://dx.doi.org/10.1136/adc.79.2.120PMID: 9797591.
63. Harrison K, Vlahov D, Jones K, Charron K, Clements ML. Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Nov 1;10 (3):386-90.doi: http://dx.doi.org/10.1097/00042560-199511000-00012PMID: 7552502.
64. Harth SC, Thong YH. Parental perceptions and attitudes about informed consent in clinical research involving children. Soc Sci Med. 1995 Jun;40 (11):1573-7.doi: http://dx.doi.org/10.1016/0277-9536 (94)00412-MPMID: 7667661.
65. Estey A, Wilkin G, Dossetor J. Are research subjects able to retain the information they are given during the consent process. Health Law Rev. 1994;3:37-41.
66. Howard JM, DeMets D. How informed is informed consent? The BHAT experience. Control Clin Trials. 1981 Dec;2 (4):287-303.doi: http://dx.doi.org/10.1016/0197-2456 (81)90019-2PMID: 6120794.
67. Griffin JM, Struve JK, Collins D, Liu A, Nelson DB, Bloomfield HE. Long term clinical trials: how much information do participants retain from the informed consent process? Contemp Clin Trials. 2006 Oct;27 (5):441-8.doi: http://dx.doi.org/10.1016/j.cct.2006.04.006PMID: 16798101.
68. Guarino P, Lamping DL, Elbourne D, Carpenter J, Peduzzi P. A brief measure of perceived understanding of informed consent in a clinical trial was validated. J Clin Epidemiol. 2006 Jun;59 (6):608-14.doi: http://dx.doi.org/10.1016/j.jclinepi.2005.11.009PMID: 16713523.
69. Barrett R. Quality of informed consent: measuring understanding among participants in oncology clinical trials. Oncol Nurs Forum. 2005 Jul;32 (4):751-5.doi: http://dx.doi.org/10.1188/05.ONF.751-755PMID: 15990904.
70. Sugarman J, Lavori PW, Boeger M, Cain C, Edsond R, Morrison V, et al. Evaluating the quality of informed consent. Clin Trials. 2005;2 (1):34-41.doi: http://dx.doi.org/10.1191/1740774505cn066oaPMID: 16279577.
71. Simon CM, Siminoff LA, Kodish ED, Burant C. Comparison of the informed consent process for randomized clinical trials in pediatric and adult oncology. J Clin Oncol. 2004 Jul 1;22 (13):2708-17.doi: http://dx.doi.org/10.1200/JCO.2004.10.034PMID: 15226338.
72. Pentz RD, Flamm AL, Sugarman J, Cohen MZ, Daniel Ayers G, Herbst RS, et al. Study of the media’s potential influence on prospective research participants’ understanding of and motivations for participation in a high-profile phase I trial. J Clin Oncol. 2002 Sep 15;20 (18):3785-91.doi: http://dx.doi.org/10.1200/JCO.2002.04.084PMID: 12228198.
73. Cohen L, de Moor C, Amato RJ. The association between treatment-specific optimism and depressive symptomatology in patients enrolled in a phase I cancer clinical trial. Cancer. 2001 May 15;91 (10):1949-55.doi: http://dx.doi.org/10.1002/1097-0142 (20010515)91:10<1949::AID-CNCR1218>3.0.CO;2-APMID: 11346878.
74. Fortney JA. Assessing recall and understanding of informed consent in a contraceptive clinical trial. Stud Fam Plann. 1999 Dec;30 (4):339-46.doi: http://dx.doi.org/10.1111/j.1728-4465.1999.t01-5-.xPMID: 10674329.
75. Hutchison C. Phase I trials in cancer patients: participants’ perceptions. Eur J Cancer Care (Engl). 1998 Mar;7 (1):15-22.doi: http://dx.doi.org/10.1046/j.1365-2354.1998.00062.xPMID: 9582747.
76. Négrier S, Lanier-Demma F, Lacroix-Kante V, Chauvin F, Saltel P, Mercatello A, et al. Evaluation of the informed consent procedure in cancer patients candidate to immunotherapy. Eur J Cancer. 1995 Sep;31A (10):1650-2.doi: http://dx.doi.org/10.1016/0959-8049 (95)00329-HPMID: 7488418.
77. Tankanow RM, Sweet BV, Weiskopf JA. Patients’ perceived understanding of informed consent in investigational drug studies. Am J Hosp Pharm. 1992 Mar;49 (3):633-5.PMID: 1598945.
78. Rodenhuis S, van den Heuvel WJ, Annyas AA, Koops HS, Sleijfer DT, Mulder NH. Patient motivation and informed consent in a phase I study of an anticancer agent. Eur J Cancer Clin Oncol. 1984 Apr;20 (4):457-62.doi: http://dx.doi.org/10.1016/0277-5379 (84)90229-3PMID: 6539201.
79. Penman DT, Holland JC, Bahna GF, Morrow G, Schmale AH, Derogatis LR, et al. Informed consent for investigational chemotherapy: patients’ and physicians’ perceptions. J Clin Oncol. 1984 Jul;2 (7):849-55.PMID: 6737023.
80. Goodman NW, Cooper GM, Malins AF, Prys-Roberts C. The validity of informed consent in a clinical study. Anaesthesia. 1984 Sep;39 (9):911-6.doi: http://dx.doi.org/10.1111/j.1365-2044.1984.tb06582.xPMID: 6545095.
81. Riecken HW, Ravich R. Informed consent to biomedical research in Veterans Administration Hospitals. JAMA. 1982 Jul 16;248 (3):344-8.doi: http://dx.doi.org/10.1001/jama.1982.03330030050025PMID: 7045434.
82. Bergler JH, Pennington AC, Metcalfe M, Freis ED. Informed consent: how much does the patient understand? Clin Pharmacol Ther. 1980 Apr;27 (4):435-40.doi: http://dx.doi.org/10.1038/clpt.1980.60PMID: 6987027.
83. Ritsuko A, Noda K, Etsuko S, Etsuko M, Tomoko S, Midori N, et al. [Survey of participants to clinical trial in Fukuoka university hospital: relationship between the participant’s understanding of informed consent and their feeling of unease for clinical trials]. Fukuoka Daigaku Igaku Kiyō. 2006;33 (1):25-9. Japanese.
84. Paediatric European Network for Treatment of AIDS. Parents’ attitudes to their HIV-infected children being enrolled into a placebo-controlled trial: the PENTA 1 trial. HIV Med. 1999 Oct;1 (1):25-31.doi: http://dx.doi.org/10.1046/j.1468-1293.1999.00005.xPMID: 11737326.
85. Ballard HO, Shook LA, Desai NS, Anand KJ. Neonatal research and the validity of informed consent obtained in the perinatal period. J Perinatol. 2004 Jul;24 (7):409-15.doi: http://dx.doi.org/10.1038/sj.jp.7211142PMID: 15152271.
86. Bertoli AM, Strusberg I, Fierro GA, Ramos M, Strusberg AM. Lack of correlation between satisfaction and knowledge in clinical trials participants: a pilot study. Contemp Clin Trials. 2007 Nov;28 (6):730-6.doi: http://dx.doi.org/10.1016/j.cct.2007.04.005PMID: 17581796.
87. Burgess E, Singhal N, Amin H, McMillan DD, Devrome H. Consent for clinical research in the neonatal intensive care unit: a retrospective survey and a prospective study. Arch Dis Child Fetal Neonatal Ed. 2003 Jul;88 (4):F280-5, discussion F285-6.doi: http://dx.doi.org/10.1136/fn.88.4.F280PMID: 12819158.
88. Chaisson LH, Kass NE, Chengeta B, Mathebula U, Samandari T. Repeated assessments of informed consent comprehension among HIV-infected participants of a three-year clinical trial in Botswana. PLoS ONE. 2011;6 (10):e22696.doi: http://dx.doi.org/10.1371/journal.pone.0022696PMID: 22046230.
89. Chappuy H, Baruchel A, Leverger G, Oudot C, Brethon B, Haouy S, et al. Parental comprehension and satisfaction in informed consent in paediatric clinical trials: a prospective study on childhood leukaemia. Arch Dis Child. 2010 Oct;95 (10):800-4.doi: http://dx.doi.org/10.1136/adc.2009.180695PMID: 20551191.
90. Chappuy H, Bouazza N, Minard-Colin V, Patte C, Brugières L, Landman-Parker J, et al. Parental comprehension of the benefits/risks of first-line randomised clinical trials in children with solid tumours: a two-stage cross-sectional interview study. BMJ Open. 2013;3 (5):e002733.doi: http://dx.doi.org/10.1136/bmjopen-2013-002733PMID: 23793670.
91. Chappuy H, Doz F, Blanche S, Gentet JC, Pons G, Tréluyer JM. Parental consent in paediatric clinical research. Arch Dis Child. 2006 Feb;91 (2):112-6.doi: http://dx.doi.org/10.1136/adc.2005.076141PMID: 16246853.
92. Chappuy H, Doz F, Blanche S, Gentet JC, Tréluyer JM. Children’s views on their involvement in clinical research. Pediatr Blood Cancer. 2008 May;50 (5):1043-6.doi: http://dx.doi.org/10.1002/pbc.21359PMID: 17960770.
93. Chenaud C, Merlani P, Luyasu S, Ricou B. Informed consent for research obtained during the intensive care unit stay. Crit Care. 2006;10 (6):R170.doi: http://dx.doi.org/10.1186/cc5120PMID: 17156444.
94. Chu SH, Jeong SH, Kim EJ, Park MS, Park K, Nam M, et al. The views of patients and healthy volunteers on participation in clinical trials: an exploratory survey study. Contemp Clin Trials. 2012 Jul;33 (4):611-9.doi: http://dx.doi.org/10.1016/j.cct.2012.02.018PMID: 22405971.
95. Constantinou M, Jhanji V, Chiang PP, Lamoureux EL, Rees G, Vajpayee RB. Determinants of informed consent in a cataract surgery clinical trial: why patients participate. Can J Ophthalmol. 2012 Apr;47 (2):118-23.doi: http://dx.doi.org/10.1016/j.jcjo.2012.01.006PMID: 22560415.
96. Cousino MK, Zyzanski SJ, Yamokoski AD, Hazen RA, Baker JN, Noll RB, et al. Communicating and understanding the purpose of pediatric phase I cancer trials. J Clin Oncol. 2012 Dec 10;30 (35):4367-72.doi: http://dx.doi.org/10.1200/JCO.2012.42.3004PMID: 23071225.
97. Durand-Zaleski IS, Alberti C, Durieux P, Duval X, Gottot S, Ravaud P, et al. Informed consent in clinical research in France: assessment and factors associated with therapeutic misconception. J Med Ethics. 2008 Sep;34 (9):e16.doi: http://dx.doi.org/10.1136/jme.2007.023473PMID: 18757616.
98. Eiser C, Davies H, Jenney M, Glaser A. Mothers’ attitudes to the randomized controlled trial (RCT): the case of acute lymphoblastic leukaemia (ALL) in children. Child Care Health Dev. 2005 Sep;31 (5):517-23.doi: http://dx.doi.org/10.1111/j.1365-2214.2005.00538.xPMID: 16101646.
99. Featherstone K, Donovan JL. Random allocation or allocation at random? Patients’ perspectives of participation in a randomised controlled trial. BMJ. 1998 Oct 31;317 (7167):1177-80.doi: http://dx.doi.org/10.1136/bmj.317.7167.1177PMID: 9794849.
100. Hazen RA, Drotar D, Kodish E. The role of the consent document in informed consent for pediatric leukemia trials. Contemp Clin Trials. 2007 Jul;28 (4):401-8.doi: http://dx.doi.org/10.1016/j.cct.2006.10.011PMID: 17196888.
101. Hereu P, Pérez E, Fuentes I, Vidal X, Suñé P, Arnau JM. Consent in clinical trials: what do patients know? Contemp Clin Trials. 2010 Sep;31 (5):443-6.doi: http://dx.doi.org/10.1016/j.cct.2010.05.004PMID: 20462521.
102. Hofmeijer J, Amelink GJ, den Hertog HM, Algra A, Kappelle LJ, van der Worp HB, et al.; PAIS investigators. Appreciation of the informed consent procedure in a randomised trial of decompressive surgery for space occupying hemispheric infarction. J Neurol Neurosurg Psychiatry. 2007 Oct;78 (10):1124-8.doi: http://dx.doi.org/10.1136/jnnp.2006.110726PMID: 17400593.
103. Itoh K, Sasaki Y, Fujii H, Ohtsu T, Wakita H, Igarashi T, et al. Patients in phase I trials of anti-cancer agents in Japan: motivation, comprehension and expectations. Br J Cancer. 1997;76 (1):107-13.doi: http://dx.doi.org/10.1038/bjc.1997.344PMID: 9218741.
104. Jenkins V, Fallowfield L. Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy. Br J Cancer. 2000 Jun;82 (11):1783-8.doi: http://dx.doi.org/10.1054/bjoc.2000.1142PMID: 10839291.
105. Kass NE, Maman S, Atkinson J. Motivations, understanding, and voluntariness in international randomized trials. IRB. 2005 Nov-Dec;27 (6):1-8.doi: http://dx.doi.org/10.2307/3563534PMID: 16425478.
106. Kenyon S, Dixon-Woods M, Jackson CJ, Windridge K, Pitchforth E. Participating in a trial in a critical situation: a qualitative study in pregnancy. Qual Saf Health Care. 2006 Apr;15 (2):98-101.doi: http://dx.doi.org/10.1136/qshc.2005.015636PMID: 16585108.
107. Kiguba R, Kutyabami P, Kiwuwa S, Katabira E, Sewankambo NK. Assessing the quality of informed consent in a resource-limited setting: a cross-sectional study. BMC Med Ethics. 2012;13 (1):21.doi: http://dx.doi.org/10.1186/1472-6939-13-21PMID: 22906301.
108. Lidz CW, Appelbaum PS, Grisso T, Renaud M. Therapeutic misconception and the appreciation of risks in clinical trials. Soc Sci Med. 2004 May;58 (9):1689-97.doi: http://dx.doi.org/10.1016/S0277-9536 (03)00338-1PMID: 14990370.
109. Leroy T, Christophe V, Penel N, Antoine P, Clisant S. Factual understanding of randomized clinical trials: a multicenter case-control study in cancer patients. Invest New Drugs. 2011 Aug;29 (4):700-5.doi: http://dx.doi.org/10.1007/s10637-009-9315-8PMID: 19760365.
110. Levi RB, Marsick R, Drotar D, Kodish ED. Diagnosis, disclosure, and informed consent: learning from parents of children with cancer. J Pediatr Hematol Oncol. 2000 Jan-Feb;22 (1):3-12.doi: http://dx.doi.org/10.1097/00043426-200001000-00002PMID: 10695815.
111. Manafa O, Lindegger G, Ijsselmuiden C. Informed consent in an antiretroviral trial in Nigeria. Indian J Med Ethics. 2007 Jan-Mar;4 (1):26-30.PMID: 18630217.
112. McNally T, Grigg J. Parents’ understanding of a randomised double-blind controlled trial. Paediatr Nurs. 2001 May;13 (4):11-4.doi: http://dx.doi.org/10.7748/paed2001.05.13.4.11.c736PMID: 12025022.
113. Mangset M, Førde R, Nessa J, Berge E, Wyller TB. I don’t like that, it’s tricking people too much…: acute informed consent to participation in a trial of thrombolysis for stroke. J Med Ethics. 2008 Oct;34 (10):751-6.doi: http://dx.doi.org/10.1136/jme.2007.023168PMID: 18827109.
114. Meneguin S, Zoboli EL, Domingues RZ, Nobre MR, César LA. [Informed consent as viewed by patients participating in cardiology drug trial]. Arq Bras Cardiol. 2010 Jan;94 (1):4-9. Portuguese.doi: http://dx.doi.org/10.1590/S0066-782X2010000100003PMID: 20414520.
115. Miller VA, Baker JN, Leek AC, Hizlan S, Rheingold SR, Yamokoski AD, et al. Adolescent perspectives on phase I cancer research. Pediatr Blood Cancer. 2013 May;60 (5):873-8.doi: http://dx.doi.org/10.1002/pbc.24326PMID: 23034985.
116. Mills N, Donovan JL, Smith M, Jacoby A, Neal DE, Hamdy FC. Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study. Control Clin Trials. 2003 Jun;24 (3):272-82.doi: http://dx.doi.org/10.1016/S0197-2456 (03)00020-5PMID: 12757993.
117. Nurgat ZA, Craig W, Campbell NC, Bissett JD, Cassidy J, Nicolson MC. Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy. Br J Cancer. 2005 Mar 28;92 (6):1001-5.doi: http://dx.doi.org/10.1038/sj.bjc.6602423PMID: 15770219.
118. Ockene IS, Miner J, Shannon TA, Gore JM, Weiner BH, Ball SP. The consent process in the Thrombolysis in Myocardial Infarction (TIMI-phase I) trial. Clin Res. 1991 Feb;39 (1):13-7.PMID: 1999082.
119. Petersen I, Spix C, Kaatsch P, Graf N, Janka G, Kollek R. Parental informed consent in pediatric cancer trials: a population-based survey in Germany. Pediatr Blood Cancer. 2013 Mar;60 (3):446-50.doi: http://dx.doi.org/10.1002/pbc.24330PMID: 23015470.
120. Queiroz da Fonseca O, Lie RK. Comprehension of the informed consent form and general knowledge of vaccines among potential participants for an HIV vaccine trial in Brazil. Int J Pharm Med. 1999;13 (5):253-60.
121. Russell FM, Carapetis JR, Liddle H, Edwards T, Ruff TA, Devitt J. A pilot study of the quality of informed consent materials for Aboriginal participants in clinical trials. J Med Ethics. 2005 Aug;31 (8):490-4.doi: http://dx.doi.org/10.1136/jme.2002.002279PMID: 16076978.
122. Schaeffer MH, Krantz DS, Wichman A, Masur H, Reed E, Vinicky JK. The impact of disease severity on the informed consent process in clinical research. Am J Med. 1996 Mar;100 (3):261-8.doi: http://dx.doi.org/10.1016/S0002-9343 (97)89483-1PMID: 8629670.
123. Coulibaly-Traoré D, Msellati P, Vidal L, Ekra CW, Dabis F. [The Ditrame (ANRS 049) clinical trial aimed at reducing the mother-child transmission of HIV in Abidjan. Participants’ understanding of the trial principles]. Presse Med. 2003 Mar 1;32 (8):343-50. French.PMID: 12712680.
124. Ducrocq X, Taillandier L, Anxionnat R, Lacour JC, Debouverie M, Lanotte L, et al. [Ethical approach to informed consent for participation in clinical studies in acute cerebral infarct]. Presse Med. 2000 Jul 8-15;29 (24):1335-40. French.PMID: 10938684.
125. Schutta KM, Burnett CB. Factors that influence a patient’s decision to participate in a phase I cancer clinical trial. Oncol Nurs Forum. 2000 Oct;27 (9):1435-8.PMID: 11058975.
126. Snowdon C, Garcia J, Elbourne D. Making sense of randomization; responses of parents of critically ill babies to random allocation of treatment in a clinical trial. Soc Sci Med. 1997 Nov;45 (9):1337-55.doi: http://dx.doi.org/10.1016/S0277-9536 (97)00063-4PMID: 9351153.
127. Stenson BJ, Becher JC, McIntosh N. Neonatal research: the parental perspective. Arch Dis Child Fetal Neonatal Ed. 2004 Jul;89 (4):F321-4.doi: http://dx.doi.org/10.1136/adc.2002.021931PMID: 15210665.
128. Unguru Y, Sill AM, Kamani N. The experiences of children enrolled in pediatric oncology research: implications for assent. Pediatrics. 2010 Apr;125 (4):e876-83.doi: http://dx.doi.org/10.1542/peds.2008-3429PMID: 20351001.
129. Yoong J, Jefford M, Mileshkin L. Patients’ understanding of clinical trials needs to be assessed in the context of understanding of overall goals of care. Support Care Cancer. 2011 Aug;19 (8):1067-8.doi: http://dx.doi.org/10.1007/s00520-011-1201-1PMID: 21637973.
130. Verheggen FW, Jonkers R, Kok G. Patients’ perceptions on informed consent and the quality of information disclosure in clinical trials. Patient Educ Couns. 1996 Nov;29 (2):137-53.doi: http://dx.doi.org/10.1016/0738-3991 (96)00859-2PMID: 9006231.
131. Country and lending groups [Internet]. Washington: World Bank; 2014. Available from: http://data.worldbank.org/about/country-and-lending-groups [cited 2014 Dec 12].
132. Idänpäänheikkilä JE. WHO guidelines for good clinical practice (GCP) for trials on pharmaceutical products: responsibilities of the investigator. Ann Med. 1994 Apr;26 (2):89-94.doi: http://dx.doi.org/10.3109/07853899409147334PMID: 8024733.
133. Moreno J, Caplan AL, Wolpe PR. Updating protections for human subjects involved in research. Project on Informed Consent, Human Research Ethics Group. JAMA. 1998 Dec 9;280 (22):1951-8.doi: http://dx.doi.org/10.1001/jama.280.22.1951PMID: 9851484.
134. de Melo-Martín I, Ho A. Beyond informed consent: the therapeutic misconception and trust. J Med Ethics. 2008 Mar;34 (3):202-5.doi: http://dx.doi.org/10.1136/jme.2006.019406PMID: 18316464.
135. Bergenmar M, Molin C, Wilking N, Brandberg Y. Knowledge and understanding among cancer patients consenting to participate in clinical trials. Eur J Cancer. 2008 Nov;44 (17):2627-33.doi: http://dx.doi.org/10.1016/j.ejca.2008.08.013PMID: 18818068.
136. Durand-Zaleski IS, Alberti C, Durieux P, Duval X, Gottot S, Ravaud P, et al. Informed consent in clinical research in France: assessment and factors associated with therapeutic misconception. J Med Ethics. 2008 Sep;34 (9):e16.doi: http://dx.doi.org/10.1136/jme.2007.023473PMID: 18757616.
137. Ballard HO, Shook LA, Desai NS, Anand KJ. Neonatal research and the validity of informed consent obtained in the perinatal period. J Perinatol. 2004 Jul;24 (7):409-15.doi: http://dx.doi.org/10.1038/sj.jp.7211142PMID: 15152271.
138. Miller FG, Joffe S. Phase 1 oncology trials and informed consent. J Med Ethics. 2013 Dec;39 (12):761-4.doi: http://dx.doi.org/10.1136/medethics-2012-100832PMID: 23161617.
139. Tamariz L, Palacio A, Robert M, Marcus EN. Improving the informed consent process for research subjects with low literacy: a systematic review. J Gen Intern Med. 2013 Jan;28 (1):121-6.doi: http://dx.doi.org/10.1007/s11606-012-2133-2PMID: 22782275.
140. Flory J, Emanuel E. Interventions to improve research participants’ understanding in informed consent for research: a systematic review. JAMA. 2004 Oct 6;292 (13):1593-601.doi: http://dx.doi.org/10.1001/jama.292.13.1593PMID: 15467062.
141. Hyder AA, Rattani A, Krubiner C, Bachani AM, Tran NT. Ethical review of health systems research in low- and middle-income countries: a conceptual exploration. Am J Bioeth. 2014;14 (2):28-37.doi: http://dx.doi.org/10.1080/15265161.2013.868950PMID: 24521334.
142. Cargan L. Doing social research. Lanham: Rowman and Littlefield Publishers; 2007.
143. Takemura Y, Sakurai Y, Yokoya S, Otaki J, Matsuoka T, Ban N, et al. Open-ended questions: are they really beneficial for gathering medical information from patients? Tohoku J Exp Med. 2005 Jun;206 (2):151-4.doi: http://dx.doi.org/10.1620/tjem.206.151PMID: 15888971.
144. Faralli C. Informed consent in medicine: ethical and juridical aspects. Milan: Salute e Società; 2013.
145. Isles AF. Understood consent versus informed consent: a new paradigm for obtaining consent for pediatric research studies. Front Pediatr. 2013;1:38.doi: http://dx.doi.org/10.3389/fped.2013.00038PMID: 24400284.
146. Nishimura A, Carey J, Erwin PJ, Tilburt JC, Murad MH, McCormick JB. Improving understanding in the research informed consent process: a systematic review of 54 interventions tested in randomized control trials. BMC Med Ethics. 2013;14 (1):28.doi: http://dx.doi.org/10.1186/1472-6939-14-28PMID: 23879694.
147. Baker JN, Leek AC, Salas HS, Drotar D, Noll R, Rheingold SR, et al. Suggestions from adolescents, young adults, and parents for improving informed consent in phase 1 pediatric oncology trials. Cancer. 2013 Dec 1;119 (23):4154-61.doi: http://dx.doi.org/10.1002/cncr.28335PMID: 24006119.
148. Terranova G, Ferro M, Carpeggiani C, Recchia V, Braga L, Semelka RC, et al. Low quality and lack of clarity of current informed consent forms in cardiology: how to improve them. JACC Cardiovasc Imaging. 2012 Jun;5 (6):649-55.doi: http://dx.doi.org/10.1016/j.jcmg.2012.03.007PMID: 22698536.
149. Mårtenson EK, Fägerskiöld AM. A review of children’s decision-making competence in health care. J Clin Nurs. 2008 Dec;17 (23):3131-41.doi: http://dx.doi.org/10.1111/j.1365-2702.2006.01920.xPMID: 18005126.
150. Kluge EH. Informed consent by children: the new reality. CMAJ. 1995 May 1;152 (9):1495-7.PMID: 7728701.
151. Cox DR. Combination of data. In: Kotz S, Johnson NL, Read CB, Balakrishnan N, Vidakovic B, editors. Encyclopedia of statistical sciences. 2nd ed. Hoboken: John Wiley & Sons; 2006.pp. 1074-81.
152. Baker WL, White CM, Cappelleri JC, Kluger J, Coleman CI; Health Outcomes, Policy, and Economics (HOPE) Collaborative Group. Understanding heterogeneity in meta-analysis: the role of meta-regression. Int J Clin Pract. 2009 Oct;63 (10):1426-34.doi: http://dx.doi.org/10.1111/j.1742-1241.2009.02168.xPMID: 19769699.
153. Huy NT, Van Giang T, Thuy DH, Kikuchi M, Hien TT, Zamora J, et al. Factors associated with dengue shock syndrome: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2013;7 (9):e2412.doi: http://dx.doi.org/10.1371/journal.pntd.0002412PMID: 24086778.
154. Ioannidis JP, Patsopoulos NA, Rothstein HR. Reasons or excuses for avoiding meta-analysis in forest plots. BMJ. 2008 Jun 21;336 (7658):1413-5.doi: http://dx.doi.org/10.1136/bmj.a117PMID: 18566080.